Fullerene Nanomedicine to Enhance Neuronal Adenosine Triphosphate Production Capacity

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$69,996.00
Award Year:
2009
Program:
SBIR
Phase:
Phase I
Contract:
W911NF-10-C-0010
Award Id:
92165
Agency Tracking Number:
A092-059-0905
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
1 Riverside Circle, Suite 400, Roanoke, VA, 24016
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
627132913
Principal Investigator:
ZhiguoZhou
Principal Investigator
(434) 483-4234
submissions@lunainnovations.com
Business Contact:
MaggieHudson
Contracts Administrator
(434) 483-4254
submissions307@lunainnovations.com
Research Institute:
n/a
Abstract
Cognitive performances are significantly reduced for older soldiers, due to the reduced production of the primary energy molecule of the body - adenosine triphosphate. The aging-dependent mitochondrial insufficiency is thought to play a dominating role. The development of a therapeutic drug which can enhance ATP production and improve energetic capability is crucial to maintain soldiers' performance and extend their duty-time. The current attempts to counter mitochondrial insufficiency include frequent exercise and antioxidants, but the effects are very limited. Luna Innovations proposes to use nanomedicine technology to develop prototype compounds with stimulatory effects on neuronal ATP production. Luna has developed an extensive portfolio of fullerene nanosphere compounds which showed promises in treating aging-related diseases. Fullerene nanospheres are thought to scavenge the toxic free radicals generated in mitochondria, enhance the electron transport capacity in oxidative phosphorylation, and build a greater potential gradient across the inner membrane, efficiently driving ATP Synthase. In Phase I, Luna will develop and validate a high throughput screening assay based on the ATP-requiring luciferin-luciferase bioluminescence, and test nanosphere compounds to build a structure-activity relationship for designing and testing more compounds in Phase II.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government